From January 22, 2024 to March 31, 2024, the company has repurchased 25,705,695 shares, representing 1% for CNY 119.53 million. With this, the company has completed the repurchase of 25,705,695 shares, representing 1% for CNY 119.53 million under the buyback announced on January 23, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 CNY | +0.41% | +0.61% | -2.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.18% | 1.74B | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- 600572 Stock
- News Zhejiang CONBA Pharmaceutical Co.,Ltd.
- Tranche Update on Zhejiang CONBA Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 23, 2024.